Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas - an applicational observation von Gellrich, S., Muche, J.M., Wilks, A., Jasch, K.C., Voit, C., Fischer, T., Audring, H., Sterry, W.

Volltext